Tag Archives: EUROPA
September 2010 Br J Cardiol 2010;17:211-14
News from the 2010 Congress of the European Society of Cardiology
Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. Highlights of this year’s European Society of Cardiology Congress, held in Stockholm, Sweden, from August 28th to September 1st included a new drug which benefits heart failure by slowing heart rate, and more exciting results from oral compounds that could replace warfarin in various indications. SHIFT: ivabradine shows benefit in heart failure
May 2004 Br J Cardiol 2004;11:195-04
Management of coronary artery disease: implications of the EUROPA trial
Kim M Fox
No content available
January 2004 Br J Cardiol 2004;11:65-8
The ACTION, EUROPA and IONA trials: similarities, differences, outcomes and expected outcome
Johannes A Kragten, Gilbert Wagener
No content available
March 2002 Br J Cardiol 2002;9:158-62
The clinical application of ACE inhibitors in coronary artery disease
Abba Gomma, John Henderson, Henry Purcell, Kim Fox
No content available
For healthcare professionals only
